Loading company…
Qianren Pharmaceutical researches, develops, manufactures and sells drugs across several therapeutic areas.
Founded in Lianyungang, China, in 2016, Qianren Pharmaceutical develops and sells cardiovascular, respiratory, digestive, anti-tumor and anti-diabetic medicines. Its products include Sitagliptin Metformin Extended-Release Tablets, Eperisone Hydrochloride Tablets and Mesalazine Enteric-Coated Tablets. In December 2025, it raised an undisclosed amount of Series A+ funding from returning investor Jiangsu Jinqiao Private Equity Fund Management. The funding is intended to advance clinical development and build its R&D platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in